Holden SA - Search Results

1

Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.

Teicher BA, Herman TS, Tanaka J, Eder JP, Holden SA, Bubley G, Coleman CN, Frei E 3rd. Teicher BA, et al. Among authors: holden sa. Cancer Res. 1991 Feb 15;51(4):1086-91. Cancer Res. 1991. PMID: 1825474

2

Effect of a bovine hemoglobin preparation (SBHS) on the response of two murine solid tumors to radiation therapy or chemotherapeutic alkylating agents.

Teicher BA, Holden SA, Ara G, Herman TS, Hopkins RE, Menon K. Teicher BA, et al. Among authors: holden sa. Biomater Artif Cells Immobilization Biotechnol. 1992;20(2-4):657-60. doi: 10.3109/10731199209119697. Biomater Artif Cells Immobilization Biotechnol. 1992. PMID: 1391491

3

Enhancement by perflusion emulsion (Oxygent) and carbogen breathing of the tumor growth delay of the FSaIIC fibrosarcoma after treatment with antitumor alkylating agents.

Holden SA, Teicher BA, Ha C, Ara G, Herman TS. Holden SA, et al. Biomater Artif Cells Immobilization Biotechnol. 1992;20(2-4):895-8. doi: 10.3109/10731199209119736. Biomater Artif Cells Immobilization Biotechnol. 1992. PMID: 1391529

4

Minocycline in combination with chemotherapy or radiation therapy in vitro and in vivo.

Sotomayor EA, Teicher BA, Schwartz GN, Holden SA, Menon K, Herman TS, Frei E 3rd. Sotomayor EA, et al. Among authors: holden sa. Cancer Chemother Pharmacol. 1992;30(5):377-84. doi: 10.1007/BF00689966. Cancer Chemother Pharmacol. 1992. PMID: 1505076

5

Interaction of D,L- and D-tetraplatin with hyperthermia in vitro and in vivo.

Epelbaum R, Teicher BA, Holden SA, Ara G, Varshney A, Herman TS. Epelbaum R, et al. Among authors: holden sa. Eur J Cancer. 1992;28A(4-5):794-800. doi: 10.1016/0959-8049(92)90117-k. Eur J Cancer. 1992. PMID: 1524897

6

Enhancement of alkylating agent activity by SR-4233 in the FSaIIC murine fibrosarcoma.

Holden SA, Teicher BA, Ara G, Herman TS, Coleman CN. Holden SA, et al. J Natl Cancer Inst. 1992 Feb 5;84(3):187-93. doi: 10.1093/jnci/84.3.187. J Natl Cancer Inst. 1992. PMID: 1542129

7

Response of subpopulations of the FSall C fibrosarcoma to low dose x-rays and various potential enhancing agents.

Tanaka J, Holden SA, Herman TS, Teicher BA. Tanaka J, et al. Among authors: holden sa. Anticancer Res. 1992 May-Jun;12(3):1029-33. Anticancer Res. 1992. PMID: 1622113

8

A new concentrated perfluorochemical emulsion and carbogen breathing as an adjuvant to treatment with antitumor alkylating agents.

Teicher BA, Holden SA, Ara G, Ha CS, Herman TS, Northey D. Teicher BA, et al. Among authors: holden sa. J Cancer Res Clin Oncol. 1992;118(7):509-14. doi: 10.1007/BF01225265. J Cancer Res Clin Oncol. 1992. PMID: 1624542

9

Efficacy of pentoxifylline as a modulator of alkylating agent activity in vitro and in vivo.

Teicher BA, Holden SA, Herman TS, Epelbaum R, Pardee AB, Dezube B. Teicher BA, et al. Among authors: holden sa. Anticancer Res. 1991 Jul-Aug;11(4):1555-60. Anticancer Res. 1991. PMID: 1746913

10

Addition of mitomycin C to cis-diamminedichloroplatinum(II)/hyperthermia/radiation therapy in the FSaIIC fibrosarcoma.

Herman TS, Teicher BA, Holden SA. Herman TS, et al. Among authors: holden sa. Int J Hyperthermia. 1991 Nov-Dec;7(6):893-903. doi: 10.3109/02656739109056457. Int J Hyperthermia. 1991. PMID: 1806643 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters